These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 6886984)

  • 1. Membrane-coated tablets: a system for the controlled release of drugs.
    Källstrand G; Ekman B
    J Pharm Sci; 1983 Jul; 72(7):772-5. PubMed ID: 6886984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of an osmotic pump system for controlled delivery of diclofenac sodium.
    Emara LH; Taha NF; Badr RM; Mursi NM
    Drug Discov Ther; 2012 Oct; 6(5):269-77. PubMed ID: 23229148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro study of gastrointestinal diffusion system using disopyramide phosphate.
    Jedras Z; Janicki S
    Pharmazie; 1987 Dec; 42(12):842-4. PubMed ID: 3444847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Constant potassium chloride release from microporous membrane-coated tablets prepared with aqueous colloidal polymer dispersions.
    Bodmeier R; Paeratakul O
    Pharm Res; 1991 Mar; 8(3):355-9. PubMed ID: 2052524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lithium acetate gastrointestinal diffusion system. Part 1: Lithium acetate single-unit gastrointestinal diffusion system: preparation and release rate studies.
    Janicki S; Jedras Z
    Pharmazie; 1990 Jan; 45(1):45-7. PubMed ID: 2333312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An Integrative QbD Approach for the Development and Optimization of Controlled Release Compressed Coated Formulation of Water-Soluble Drugs.
    Shah V; Khambhla E; Nivsarkar M; Trivedi R; Patel RK
    AAPS PharmSciTech; 2022 Apr; 23(5):120. PubMed ID: 35460024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Release characteristics and in vitro-in vivo correlation of pulsatile pattern for a pulsatile drug delivery system activated by membrane rupture via osmotic pressure and swelling.
    Lin HL; Lin SY; Lin YK; Ho HO; Lo YW; Sheu MT
    Eur J Pharm Biopharm; 2008 Sep; 70(1):289-301. PubMed ID: 18539015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel zein-based dry coating tablet design for zero-order release.
    Guo HX; Shi YP
    Int J Pharm; 2009 Mar; 370(1-2):81-6. PubMed ID: 19100825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of hot-melt coating process for designing a lipid based controlled release drug delivery system for highly aqueous soluble drugs.
    Knezevic Z; Gosak D; Hraste M; Rausl D; Khan MZ
    Chem Pharm Bull (Tokyo); 2009 May; 57(5):464-71. PubMed ID: 19420776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of novel one-step dry-coated tablets as a platform for delayed-release tablets.
    Ozeki Y; Ando M; Watanabe Y; Danjo K
    J Control Release; 2004 Feb; 95(1):51-60. PubMed ID: 15013231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of formulation parameters on the release characteristics of propranolol from asymmetric membrane coated tablets.
    Garg A; Gupta M; Bhargava HN
    Eur J Pharm Biopharm; 2007 Nov; 67(3):725-31. PubMed ID: 17543513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design and evaluation of osmotic pump tablets of naproxen sodium.
    Ramakrishna N; Mishra B
    Pharmazie; 2001 Dec; 56(12):958-62. PubMed ID: 11802660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Formulation, in vitro evaluation and study of variables on tri-layered gastro-retentive delivery system of diltiazem HCl.
    Raut Desai S; Rohera BD
    Drug Dev Ind Pharm; 2014 Mar; 40(3):380-9. PubMed ID: 23369093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation and characterization of pH-independent sustained release tablet containing solid dispersion granules of a poorly water-soluble drug.
    Tran HT; Park JB; Hong KH; Choi HG; Han HK; Lee J; Oh KT; Lee BJ
    Int J Pharm; 2011 Aug; 415(1-2):83-8. PubMed ID: 21641985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of drug release kinetics from hydroxypropyl methyl cellulose matrix tablets using polyvinyl pyrrolidone.
    Hardy IJ; Windberg-Baarup A; Neri C; Byway PV; Booth SW; Fitzpatrick S
    Int J Pharm; 2007 Jun; 337(1-2):246-53. PubMed ID: 17306477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sustained release of a model macromolecule from preparations with erodible core.
    Hasirci VN; Kamel IL
    Biomaterials; 1988 Sep; 9(5):424-8. PubMed ID: 2465028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A designer's polymer as an oral drug carrier (tablet) with pseudo-zero-order release kinetics.
    Nujoma YN; Kim CJ
    J Pharm Sci; 1996 Oct; 85(10):1091-5. PubMed ID: 8897277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanistic analysis of drug release from tablets with membrane controlled drug delivery.
    Strübing S; Metz H; Mäder K
    Eur J Pharm Biopharm; 2007 Apr; 66(1):113-9. PubMed ID: 17101269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mucoadhesive elementary osmotic pump tablets of trimetazidine for controlled drug delivery and reduced variability in oral bioavailability.
    Alam N; Beg S; Rizwan M; Ahmad A; Ahmad FJ; Ali A; Aqil M
    Drug Dev Ind Pharm; 2015 Apr; 41(4):692-702. PubMed ID: 24669975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design of tablets for the delayed and complete release of poorly water-soluble weak base drugs using SBE7M-β-CD as a solubilizing agent.
    Rao VM; Zannou EA; Stella VJ
    J Pharm Sci; 2011 Apr; 100(4):1576-87. PubMed ID: 24081477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.